The Sydney Neuroimaging Analysis Centre has received government funding to market its AI-powered software for brain disease analysis. Their flagship product, iQ-solutions, has received clearance from the TGA and aims to improve detection and management of conditions like multiple sclerosis and dementia. With funding from ANDHealth+ program, SNAC plans to commercialize their software for MRI scan analysis. Additionally, they have developed a data informatics platform and an AI-based software for detecting cerebral hemorrhage. SNAC’s products are currently being used at St Vincent’s Hospital Sydney. With global market clearances, SNAC aims to capitalize on the growing demand for quantitative neuroimaging solutions through a subscription-based model.
Source link
Sydney Neuroimaging Analysis Centre bags grant for dementia, multiple sclerosis analysis AI
